Category: Insulet Corp.Syndicate content

Diabetes: Abbott recalls blood glucose meters over false readings

March 17, 2014 by Arezu Sarvestani

Abbott Diabetes Care recalls FreeStyle and FreeStyle Flash blood glucose meters users over concerns that the devices may report erroneously low readings.

Updated March 17, 2014, at 4:30 pm. with comments from Abbott.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet boosts sales, slashes losses, notes Mass. state inquiry

February 28, 2014 by Arezu Sarvestani

Diabetes devices maker Insulet posts a stellar quarter that beats Wall Street's expectations and notes a pending Massachusetts Attorney General inquiry.

Diabetes: Insulet gains on boost in sales, narrowing losses in Q4 and 2013

Massachusetts-based Insulet (NSDQ:PODD) got some Wall Street love today after posing a significant bump in sales for its 4th quarter and the full year of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Insulet expands into new HQ

February 10, 2014 by Chris Walker

Insulet plans an expansion into new headquarters, moving from Bedford, Mass., to nearby Billerica.

Insulet moving HQ down the street

Insulet (NSDQ:PODD) is moving its corporate headquarters to Billerica, Mass., 9 minutes away from the company's current home in Bedford, Mass.

Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar

January 16, 2014 by Arezu Sarvestani

Insulin pump maker Insulet plans to add another 20 sales reps to its team by the end of Q1, as the company continues to see major growth in pediatric users of its tubeless OmniPod system.

Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar

Insulet (NSDQ:PODD) president & CEO Duane DeSisto is looking for a few good reps, planning to add 20 members to the company's sales force by the end of the 1st quarter.

Neuro Kinetics appoints new CFO | Personnel Moves

December 24, 2013 by Chris Walker

Neuro Kinetics named former Zoll Medical executive Michael Saporito as CFO.

fired/hired

Neuro Kinetics appointed Michael Saporito as its new CFO.

Saporito joins the Pittsburgh-based medical device company after years with LifeVest, which he helped turn around before the company was bought out by Zoll Medical.

Deals: Insulet, Amgen team up for biotech drug infusion

December 10, 2013 by Arezu Sarvestani

Insulin pump maker Insulet and biotech company Amgen plan a 5-year partnership for biotechnology medicine delivery devices.

Diabetes: Insulet, Amgen team up for biotech drug infusion

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Insulet misses Q3 expectations, tightens 2013 sales guidance

November 7, 2013 by Brad Perriello

Insulet misses the mark with its 3rd-quarter sales and earnings results and tightens its revenue forecast for the rest of the year.

Insulet misses Q3 expectations, tightens 2013 sales guidance

Insulet (NSDQ:PODD) fell short of Wall Street's expectations with its 3rd-quarter results, missing the mark for both sales and earnings and tightening its revenue outlook for the rest of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp